Analysis of pharmacoeconomics of oxycodone and acetaminophen tablets versus oxycodone hydrochloride prolonged-release tablets in the treatment of advanced cancer pain
Lists
Only you see this
Abstract
OBJECTIVE To assess the cost-effectiveness of oxycodone and acetaminophen tablets(Tylox) versus oxycodone hydrochloride prolonged-release tablets(OXY-contin) in the treatment of advanced cancer pain,providing the direction for the clinical medication. METHODS 148 patients with advanced cancer pain were treated by Tylox(n=73) or OXY-contin(n=75).After 4 weeks of treatment,the efficacy,adverse drug reactions and cost were compared,and the cost-effectiveness analysis was conducted. RESULTS The effective rates of Tylox was 86.3% and OXY-contin was 90.7%,with no significant difference(P0.05).The cost-effectiveness ratio of Tylox was 16.3 and OXY-contin was 26.3.The incidence of adverse drug reactions was lower in Tylox group. CONCLUSION The efficacy of Tylox and OXY-contin was not different.Because of lower cost-effectiveness ratio,Tylox was better choice for the treatment of advanced cancer pain.
BibTeX
@inproceedings{zhang2012analysis,
author = {Hongyu Zhang},
title = {{Analysis of pharmacoeconomics of oxycodone and acetaminophen tablets versus oxycodone hydrochloride prolonged-release tablets in the treatment of advanced cancer pain}},
booktitle = {Chinese},
year = {2012},
}Loading related content...